JSC Grindeks informs that the company has submitted its Corporate Social Responsibility Reportof 2011 to “Nasdaq OMX Riga”. Corporate Social Responsibility policy of «Grindeks» is...
Grindeks informs that the manufactured medication by the company Amitriptyline-Grindeks has received an award for “The best anti-depressant in somatic practice” in the international award...
Today, on 29 May, Grindeks participates in the conference “CEO Meets Investor”, organized by “Nasdaq OMX Baltic”, held in Vilnius, Lithuania. During the conference, Grindeks...
Today, on 11 May, in the ceremonial event, the joint stock company Grindeks has concluded “Profession Days for Pupils”. Within the project the pupils spent...
JSC Grindeks informs that Grindeks today, on 1 March, was visited by the Latvian Minister of Health Ingrīda Circene, who met with the management representatives...
Today, on 24 February, JSC Grindeks has submitted the non-audited consolidated financial statements for 2011 to “Nasdaq OMXRiga”. Non-audited financial results show that the turnover...
JSC Grindeks informs that the Company takes part in two EU-funded competence centres – “Pharma and Chemistry Competence Centre” and “Environment, Bioenergetics and Biotechnology Competence...
JSC Grindeks Foundation “For the Support of Science and Education” informs thatt oday, on 29 December, it has awarded teachers, higher educational institutions` teaching staff...
The original preparation Mildronate® GX of Grindeks has received the prestigious award and nomination “The Cardiological Medication of the Year” in the awarding ceremony of...
From October 25 to 27, JSC Grindeks will participate in the international exhibition “CPhI Worldwide 2011” in Messe Frankfurt, Germany. During the exhibition Grindeks will...
Active pharmaceutical ingredients UDCA* manufacturing unit is one of Grindeks most significant investment projects. The total contribution of the new manufacturing unit consists of 6.34...
Grindeks informs that starting this autumn in Latvian pharmacies will once again be offered the company`s manufactured vitamins. Vitamin Gritamin® series will have six products...
JSC Grindeks informs that today, on 29 March, the company is visited by the representatives of the European Commission, the Latvian Investment and Development Agency...
Joint-stock company Grindeks informs that it has established a new anti-cancer final dosage forms’ manufacturing unit, in which 400 thousand lats have been invested. Production...
JSC Grindeks informs that the company successfully continues registration of Mildronate® in the People’s Republic of China. Last week in China, Beijing Grindeks management representatives...
